Notice: The uscode.house.gov website is currently operating in a temporary format. While the United States Code remains available from its authoritative source, some website features and functionality are temporarily unavailable.
The United States Code Online is current through Public Law 119-120 (October 7, 2026).
Search & Browse Currency and Updating Classification Tables Popular Name Tool Positive Law Codification Editorial Reclassification Downloads
21 U.S.C. 353a–1: Enhanced communicationText contains those laws in effect through Public Law 119-120 (October 7, 2026).
From Title 21-FOOD AND DRUGSCHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT
Jump To: Source CreditEditorial NotesCodification

§353a–1. Enhanced communication

(a)  Submissions from State boards of pharmacy

In a manner specified by the Secretary of Health and Human Services (referred to in this section as the “Secretary”), the Secretary shall receive submissions from State boards of pharmacy⁠—

(1)  describing actions taken against compounding pharmacies, as described in subsection (b); or

(2)  expressing concerns that a compounding pharmacy may be acting contrary to section 353a of this title.

(b)  Content of submissions from State boards of pharmacy

An action referred to in subsection (a)(1) is, with respect to a pharmacy that compounds drugs, any of the following:

(1)  The issuance of a warning letter, or the imposition of sanctions or penalties, by a State for violations of a State’s pharmacy regulations pertaining to compounding.

(2)  The suspension or revocation of a State-issued pharmacy license or registration for violations of a State’s pharmacy regulations pertaining to compounding.

(3)  The recall of a compounded drug due to concerns relating to the quality or purity of such drug.

(c)  Consultation

The Secretary shall implement subsection (a) in consultation with the National Association of Boards of Pharmacy.

(d)  Notifying State boards of pharmacy

The Secretary shall immediately notify State boards of pharmacy when⁠—

(1)  the Secretary receives a submission under subsection (a)(1); or

(2)  the Secretary makes a determination that a pharmacy is acting contrary to section 353a of this title.

( Pub. L. 113–54, title I, § 105 , Nov. 27, 2013 , 127 Stat. 597 .)

Editorial Notes

Codification

Section was enacted as part of the Compounding Quality Act and also as part of the Drug Quality and Security Act, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter.